TRIB3 and hepatocellular carcinoma: Since pharmacological perturbation of ATF4 activity affected cell sensitivity to bortezomib (Figure 1C), these results raise the possibility that hepatoma cells employ high TRIB3 expression to achieve optimal ATF4 pathway activity and thereby survival under stressful conditions.